NO20020084L - Vedvarende frigivelsessammensetninger, fremgangsmåter for fremstilling av disse, og anvendelse av disse - Google Patents

Vedvarende frigivelsessammensetninger, fremgangsmåter for fremstilling av disse, og anvendelse av disse

Info

Publication number: NO20020084L
Authority: NO; Norway
Prior art keywords: sustained release; release compositions; salt; processes; preparation
Prior art date: 1999-07-15

Application number

NO20020084A

Other languages

English (en)

Norwegian (no)

Other versions

NO20020084D0 (no

Inventor

Yasutaka Igari

Yoshio Hata

Kazumichi Yamamoto

Original Assignee

Takeda Chemical Industries Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-07-15

Filing date

2002-01-08

Publication date

2002-03-14

2002-01-08 Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd

2002-01-08 Publication of NO20020084D0 publication Critical patent/NO20020084D0/no

2002-03-14 Publication of NO20020084L publication Critical patent/NO20020084L/no

Links

239000000203 mixture Substances 0.000 title abstract 3
238000013268 sustained release Methods 0.000 title abstract 3
239000012730 sustained-release form Substances 0.000 title abstract 3
238000000034 method Methods 0.000 title 1
229920000642 polymer Polymers 0.000 abstract 3
150000003839 salts Chemical class 0.000 abstract 3
XBBVURRQGJPTHH-UHFFFAOYSA-N 2-hydroxyacetic acid;2-hydroxypropanoic acid Chemical compound OCC(O)=O.CC(O)C(O)=O XBBVURRQGJPTHH-UHFFFAOYSA-N 0.000 abstract 2
UPHOPMSGKZNELG-UHFFFAOYSA-N 2-hydroxynaphthalene-1-carboxylic acid Chemical compound C1=CC=C2C(C(=O)O)=C(O)C=CC2=C1 UPHOPMSGKZNELG-UHFFFAOYSA-N 0.000 abstract 1
239000013543 active substance Substances 0.000 abstract 1
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
- A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Molecular Biology (AREA)
Biophysics (AREA)
Endocrinology (AREA)
Inorganic Chemistry (AREA)
Reproductive Health (AREA)
Diabetes (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Urology & Nephrology (AREA)
Medicinal Preparation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Biological Depolymerization Polymers (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Agricultural Chemicals And Associated Chemicals (AREA)
Polyesters Or Polycarbonates (AREA)

NO20020084A 1999-07-15 2002-01-08 Vedvarende frigivelsessammensetninger, fremgangsmåter for fremstilling av disse, og anvendelse av disse NO20020084L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
JP20188799		1999-07-15
PCT/JP2000/004683 WO2001005380A1 (fr)	1999-07-15	2000-07-13	Compositions a liberation lente, techniques de production et methodes d'utilisation

Publications (2)

Publication Number	Publication Date
NO20020084D0 NO20020084D0 (no)	2002-01-08
NO20020084L true NO20020084L (no)	2002-03-14

Family

ID=16448493

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20020084A NO20020084L (no)	1999-07-15	2002-01-08	Vedvarende frigivelsessammensetninger, fremgangsmåter for fremstilling av disse, og anvendelse av disse

Country Status (21)

Country	Link
US (2)	US7265157B1 (cs)
EP (1)	EP1197208B1 (cs)
KR (1)	KR20020012312A (cs)
CN (1)	CN1361685A (cs)
AT (1)	ATE360413T1 (cs)
AU (1)	AU5853000A (cs)
BR (1)	BR0012400A (cs)
CA (1)	CA2378714A1 (cs)
CZ (1)	CZ2002114A3 (cs)
DE (1)	DE60034568T2 (cs)
HK (1)	HK1042237A1 (cs)
HU (1)	HUP0202880A3 (cs)
IL (1)	IL147417A0 (cs)
MX (1)	MXPA02000461A (cs)
NO (1)	NO20020084L (cs)
NZ (1)	NZ516466A (cs)
PL (1)	PL352499A1 (cs)
RU (1)	RU2002103718A (cs)
SK (1)	SK342002A3 (cs)
WO (1)	WO2001005380A1 (cs)
ZA (1)	ZA200200347B (cs)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NZ505651A (en)	1998-01-16	2003-08-29	Takeda Chemical Industries Ltd	Sustained release composition comprising biologically active substance, hydroxynaphthoic acid and biodegradable polymer
AU1797800A (en)	1998-12-15	2000-07-03	Takeda Chemical Industries Ltd.	Process for producing polymer
ES2256276T5 (es)	2000-08-07	2011-02-22	Wako Pure Chemical Industries, Ltd.	Polímero de ácido láctico y procedimiento para su producción.
WO2002078669A1 (fr) *	2001-03-30	2002-10-10	Takeda Chemical Industries, Ltd.	Solutions medicinales
US20040235748A1 (en) *	2001-04-25	2004-11-25	Yasutaka Igari	Agents for preventing postoperative recurrence of premenopausal breast cancer
US6693134B2 (en)	2001-05-29	2004-02-17	Chemokine Therapeutics Corporation	Bicyclic aromatic chemokine receptor ligands
TW200526267A (en)	2001-06-29	2005-08-16	Takeda Chemical Industries Ltd	Controlled release composition and method of producing the same
CN1620285A (zh) *	2001-12-26	2005-05-25	武田药品工业株式会社	新微球和其生产方法
KR101041767B1 (ko)	2002-06-25	2011-06-17	다케다 야쿠힌 고교 가부시키가이샤	서방성 조성물의 제조 방법
AU2004259209A1 (en) *	2003-07-23	2005-02-03	Pr Pharmaceuticals, Inc.	Controlled release compositions
US20050064045A1 (en) *	2003-09-18	2005-03-24	Sheng-Ping Zhong	Injectable therapeutic formulations
US7906125B2 (en)	2003-09-18	2011-03-15	Boston Scientific Scimed, Inc.	Solid or semi-solid therapeutic formulations
TW200529890A (en)	2004-02-10	2005-09-16	Takeda Pharmaceutical	Sustained-release preparations
EP1679065A1 (en) *	2005-01-07	2006-07-12	OctoPlus Sciences B.V.	Controlled release compositions for interferon based on PEGT/PBT block copolymers
US7862552B2 (en)	2005-05-09	2011-01-04	Boston Scientific Scimed, Inc.	Medical devices for treating urological and uterine conditions
US8263109B2 (en)	2005-05-09	2012-09-11	Boston Scientific Scimed, Inc.	Injectable bulking compositions
WO2007070564A2 (en) *	2005-12-13	2007-06-21	Harkness Pharmaceuticals, Inc.	Methods of treating obesity using enterostatin
WO2007070563A2 (en) *	2005-12-13	2007-06-21	Harkness Pharmaceuticals, Inc.	Stable solid forms of enterostatin
JP2009542813A (ja) *	2006-07-11	2009-12-03	ハルクネススプハルマセウティカルス，インコーポレイテッド	飽食因子を使用して肥満を治療する方法
US7858663B1 (en) *	2007-10-31	2010-12-28	Pisgah Laboratories, Inc.	Physical and chemical properties of thyroid hormone organic acid addition salts
MY148370A (en)	2006-12-18	2013-04-15	Takeda Pharmaceutical	Sustained-release composition and method for producing the same

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU4459196A (en) *	1995-01-23	1996-08-14	Takeda Chemical Industries Ltd.	Sustained-release preparation and use
ES2221019T3 (es)	1996-10-31	2004-12-16	Takeda Chemical Industries, Ltd.	Preparacion de liberacion mantenida.
WO1998032423A1 (en) *	1997-01-29	1998-07-30	Takeda Chemical Industries, Ltd.	Sustained-release microspheres, their production and use
NZ505651A (en) *	1998-01-16	2003-08-29	Takeda Chemical Industries Ltd	Sustained release composition comprising biologically active substance, hydroxynaphthoic acid and biodegradable polymer
JPH11269094A (ja) *	1998-01-16	1999-10-05	Takeda Chem Ind Ltd	徐放性組成物、その製造法および用途
AU1797800A (en) *	1998-12-15	2000-07-03	Takeda Chemical Industries Ltd.	Process for producing polymer

2000
- 2000-07-13 HK HK02103567.5A patent/HK1042237A1/en unknown
- 2000-07-13 IL IL14741700A patent/IL147417A0/xx unknown
- 2000-07-13 AT AT00944418T patent/ATE360413T1/de not_active IP Right Cessation
- 2000-07-13 RU RU2002103718/14A patent/RU2002103718A/ru not_active Application Discontinuation
- 2000-07-13 PL PL00352499A patent/PL352499A1/xx not_active Application Discontinuation
- 2000-07-13 WO PCT/JP2000/004683 patent/WO2001005380A1/ja not_active Ceased
- 2000-07-13 MX MXPA02000461A patent/MXPA02000461A/es not_active Application Discontinuation
- 2000-07-13 DE DE60034568T patent/DE60034568T2/de not_active Expired - Fee Related
- 2000-07-13 US US10/019,786 patent/US7265157B1/en not_active Expired - Fee Related
- 2000-07-13 BR BR0012400-1A patent/BR0012400A/pt not_active IP Right Cessation
- 2000-07-13 CN CN00810405A patent/CN1361685A/zh active Pending
- 2000-07-13 NZ NZ516466A patent/NZ516466A/xx unknown
- 2000-07-13 HU HU0202880A patent/HUP0202880A3/hu unknown
- 2000-07-13 CZ CZ2002114A patent/CZ2002114A3/cs unknown
- 2000-07-13 KR KR1020027000546A patent/KR20020012312A/ko not_active Withdrawn
- 2000-07-13 CA CA002378714A patent/CA2378714A1/en not_active Abandoned
- 2000-07-13 SK SK34-2002A patent/SK342002A3/sk not_active Application Discontinuation
- 2000-07-13 AU AU58530/00A patent/AU5853000A/en not_active Abandoned
- 2000-07-13 EP EP00944418A patent/EP1197208B1/en not_active Expired - Lifetime
2002
- 2002-01-08 NO NO20020084A patent/NO20020084L/no not_active Application Discontinuation
- 2002-01-15 ZA ZA200200347A patent/ZA200200347B/en unknown
2007
- 2007-07-25 US US11/782,707 patent/US20080014237A1/en not_active Abandoned

Also Published As

Publication number	Publication date
ZA200200347B (en)	2003-03-26
PL352499A1 (en)	2003-08-25
US7265157B1 (en)	2007-09-04
HK1042237A1 (en)	2002-08-09
EP1197208A4 (en)	2004-06-30
NO20020084D0 (no)	2002-01-08
EP1197208A1 (en)	2002-04-17
BR0012400A (pt)	2002-05-21
CZ2002114A3 (cs)	2002-04-17
DE60034568D1 (de)	2007-06-06
KR20020012312A (ko)	2002-02-15
CN1361685A (zh)	2002-07-31
IL147417A0 (en)	2002-08-14
CA2378714A1 (en)	2001-01-25
US20080014237A1 (en)	2008-01-17
ATE360413T1 (de)	2007-05-15
AU5853000A (en)	2001-02-05
NZ516466A (en)	2003-02-28
HUP0202880A3 (en)	2003-04-28
EP1197208B1 (en)	2007-04-25
DE60034568T2 (de)	2008-01-03
MXPA02000461A (es)	2002-07-30
HUP0202880A2 (hu)	2003-01-28
RU2002103718A (ru)	2003-10-10
SK342002A3 (en)	2002-05-09
WO2001005380A1 (fr)	2001-01-25

Legal Events

Date	Code	Title	Description
2006-02-27	FC2A	Withdrawal, rejection or dismissal of laid open patent application

Publication	Publication Date	Title
NO20020084D0 (no)	2002-01-08	Preparater med vedvarende frigivelse, fremgangsmåter for fremstille disse og anvendelser av disse
HUP0100221A2 (hu)	2001-06-28	Nyújtott hatású készítmény és eljárás az előállítására, valamint alkalmazása
CY1117889T1 (el)	2017-05-17	Πολυμερες γαλακτικου οξεος και διεργασια για την παραγωγη αυτου
WO2001019780A3 (de)	2001-09-07	Neuartige aminodicarbonsäurederivate mit pharmazeutischen eigenschaften
WO2001019776A3 (de)	2001-11-29	Neuartige dicarbonsäurederivate mit pharmazeutischen eigenschaften
DK0839525T3 (da)	2004-11-29	Præparat med forlænget frigivelse
CA2107709A1 (en)	1994-04-13	Calcium Agent for Plants
WO1999057301A8 (en)	2000-01-06	Compounds having glucuronic acid derivatives and glucosamine derivatives in the structure, process for producing the same and utilization thereof
WO2000061568A8 (de)	2001-06-21	Mit zuckerresten substituierte 1,4-benzothiazepin-1,1-dioxidderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
IL90062A0 (en)	1989-12-15	Pyridonecarboxylic acid derivatives,their preparation and pharmaceutical compositions containing them
TR200200648T2 (tr)	2002-08-21	Farmasötik özelliklere sahip yeni dikarboksilik asit türevleri.
WO2003002092A3 (en)	2003-04-10	Controlled release composition comprising lactic acid polymer and hydroxynaphthoic acid, and method of producing the same
MXPA03011440A (es)	2004-07-01	Composicion de liberacion sostenida y proceso para producirla.
CA2336412A1 (en)	2000-01-13	Medicament for treatment of diabetes
DK0808303T3 (da)	2001-09-10	5-(4-subst.-piperidinyl-1)-3-aryl-pentansyrederivater som tachykininreceptorantagonister
NO20004919L (no)	2000-11-28	Fremgangsmåte for fremstilling av 5-hydroksybenzo[b]tiofen-3- karboksylsyrederivater
IL131216A0 (en)	2001-01-28	Drugs inhibiting progress of pterygium and postoperative recurrence of the same
EP0790252A4 (en)	1998-12-09	FUMARIC ACID DERIVATIVE AND POLYMER THEREOF
EP2239270A3 (en)	2011-01-12	Low molecular weight peptide derivatives as inhibitors of the Laminin/Nidogen interaction
JP2001510860A5 (cs)	2006-01-05
WO2002030874A3 (en)	2002-07-25	Aliphatic, cyclic amino carboxylic acids as integrin antagonists
JP4699635B2 (ja)	2011-06-15	徐放性薬剤組成物
EE03522B1 (et)	2001-10-15	Meetod kinoloonkarboksüülhapete ja naftüridiinkarboksüülhapete saamiseks vabade aluste kujul
DE69908771D1 (de)	2003-07-17	Tilidin-mesylat, verfahren zu dessen herstellung und pharmazeutische zusammensetzungen
TH101402B (th)	2010-05-26	สารผสมที่ออกฤทธิ์นาน และกรรมวิธีสำหรับผลิตสารเดียวกันนี้